Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
Status:
Completed
Trial end date:
2015-04-23
Target enrollment:
Participant gender:
Summary
A one time oral dose of ALA is taken before surgery. The medication makes the tumor visible
under ultraviolet light which allow the surgeon to see more of the tumor for a more complete
removal.